Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults

dc.contributor.authorStark, Ken
dc.contributor.authorVan Elswyk, Mary E.
dc.contributor.authorHiggins, M. Roberta
dc.contributor.authorWeatherford, Charli A.
dc.contributor.authorSalem, Norman, Jr.
dc.date.accessioned2017-11-20T18:53:33Z
dc.date.available2017-11-20T18:53:33Z
dc.date.issued2016-07-01
dc.descriptionPublished by Elsevier, and Made available in open-access under the CC-BY-4.0 International license http://creativecommons.org/licenses/by/4.0/. http:/dx.doi.org/10.1016/j.plipres.2016.05.001en
dc.description.abstractStudies reporting blood levels of the omega-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), were systematically identified in order to create a global map identifying countries and regions with different blood levels. Included studies were those of healthy adults, published in 1980 or later. A total of 298 studies met all inclusion criteria. Studies reported fatty acids in various blood fractions including plasma total lipids (33%), plasma phospholipid (32%), erythrocytes (32%) and whole blood (3.0%). Fatty acid data from each blood fraction were converted to relative weight percentages (wt.%) and then assigned to one of four discrete ranges (high, moderate, low, very low) corresponding to wt.% EPA + DHA in erythrocyte equivalents. Regions with high EPA + DHA blood levels (>8%) included the Sea of Japan, Scandinavia, and areas with indigenous populations or populations not fully adapted to Westernized food habits. Very low blood levels (<= 4%) were observed in North America, Central and South America, Europe, the Middle East, Southeast Asia, and Africa. The present review reveals considerable variability in blood levels of EPA + DHA and the very low to low range of blood EPA + DHA for most of the world may increase global risk for chronic disease. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license.en
dc.description.sponsorshipDSM Nutritional Productsen
dc.identifier.urihttp:/dx.doi.org/10.1016/j.plipres.2016.05.001
dc.identifier.urihttp://hdl.handle.net/10012/12647
dc.language.isoenen
dc.publisherElsevieren
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectPolyunsaturated Fatty-Acidsen
dc.subjectLong-Chain Omega-3-Fatty-Acidsen
dc.subjectFood Frequency Questionnaireen
dc.subjectAlpha-Linolenic-Aciden
dc.subjectCardiovascular Risk-Factorsen
dc.subjectFish-Oil Supplementationen
dc.subjectCoronary-Heart-Diseaseen
dc.subjectRandomized Controlled-Trialen
dc.subjectCost-Effectiveness Analysisen
dc.subjectPlacebo-Controlled Trialen
dc.titleGlobal survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adultsen
dc.typeArticleen
dcterms.bibliographicCitationStark, K. D., Van Elswyk, M. E., Higgins, M. R., Weatherford, C. A., & Salem, N. (2016). Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Progress in Lipid Research, 63, 132–152. https://doi.org/10.1016/j.plipres.2016.05.001en
uws.contributor.affiliation1Faculty of Applied Health Sciencesen
uws.contributor.affiliation2Kinesiologyen
uws.peerReviewStatusRevieweden
uws.scholarLevelFacultyen
uws.typeOfResourceTexten

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1-s2.0-S0163782715300333-main.pdf
Size:
1.75 MB
Format:
Adobe Portable Document Format
Description:
Publisher's version

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.46 KB
Format:
Plain Text
Description: